| | Novartis said on Tuesday it was taking its experimental medicine ligelizumab to late-stage trials after the drug showed signs of outperforming existing product Xolair in treating severe urticaria, also known as hives. | |
| Amgen Inc, updating the first trial of its bispecific antibody for multiple myeloma, said on Monday seven out of 10 patients given the second-highest dose of AMG420 responded to the drug, including four with no detectable cancer. | |
| (Reuters Health) - - Girls who are exposed before birth to chemicals commonly found in toothpaste, makeup, soap and other personal care products may hit puberty earlier than their peers who aren't exposed to these chemicals in the womb, a U.S. study suggests. | |
| Rapid advances in cancer science have increased the number of new oncology drugs being developed, but delays in regulation and approvals mean patients in Europe often wait years to be able to access them, researchers said on Tuesday. | |
| When Houaida Mabrouk heard about a government campaign that offers free hepatitis C screenings, she hesitated, afraid of testing positive. But after many from her community started visiting health clinics to get checked, she changed her mind. | |
| (Reuters Health) - - All those interactive digital toys and mobile apps designed for little kids are exactly the type of gifts parents should take off their holiday shopping lists, U.S. pediatricians say. | |
| (Reuters Health) - - Women who work rotating night shifts and also have unhealthy lifestyle habits may be much more likely to develop diabetes than peers with only one of these risk factors, a large U.S. study suggests. | |
| Roche's Hemlibra provided sustained bleed control in the largest pivotal study to date of children with a form of haemophilia, the Swiss drugmaker said on Monday. | |
| Authorities in the Houthi-held Yemeni capital Sanaa are sterilizing water supplies at wells, distribution networks and houses to help stem the world's worst outbreak of cholera. | |
| The World Health Organization (WHO) warned on Monday that gene editing may have "unintended consequences" and said it was establishing a team of experts to set clear guidelines and standards after studying ethical and safety issues. | |
| (This December 2 story corrects spelling in paragraph 5 to Alvarnas from Alvarnaz) | |
|
| |